Prais Dario, Schonfeld Tommy, Amir Jacob
Department of Pediatrics, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
Pediatrics. 2003 Sep;112(3 Pt 1):548-52. doi: 10.1542/peds.112.3.548.
Preterm infants, especially those with chronic lung disease (CLD), are considered more susceptible to severe respiratory illness from respiratory syncytial virus (RSV) infection than healthy term infants, and are therefore targeted for prophylactic administration of immune globulins. The impact of this practice on the more severe cases of bronchiolitis (i.e., pediatric intensive care unit [PICU] admission, mechanical ventilation, mortality) has not been reported to date. The aim of this study was to evaluate PICU admissions, need for mechanical ventilation, and mortality attributable to RSV bronchiolitis in Israel before the introduction of RSV prophylaxis to the country.
Prospective survey of 11 PICUs in Israel during the RSV season (November 2000-March 2001).
All patients admitted to the PICU because of bronchiolitis, and the subgroups who needed mechanical ventilation or who died, were analyzed for known risk factors, namely, prematurity, CLD, and chronic oxygen dependence.
A total of 105 patients with RSV bronchiolitis met the inclusion criteria, of whom 33 were mechanically ventilated. Most of the patients (84% total admission, 88% ventilated) were born after 32 weeks' gestation, and 89% and 88%, respectively, did not have CLD. Only 16% and 9%, respectively, met any of the American Academy of Pediatrics criteria for RSV prophylaxis, such that 84% of the whole sample and 91% of the ventilated patients were not candidates for RSV prophylaxis. Five patients died, 2 of them with cyanotic heart disease.
Most of the infants with severe RSV bronchiolitis were born at term and did not have CLD. The great majority of patients admitted to the PICU for bronchiolitis were not candidates for RSV prophylaxis. Administration of RSV prophylaxis to the predefined high-risk population could be expected to yield no significant change in PICU admissions or number of infants needing mechanical ventilation. New risk-stratified guidelines for RSV prophylaxis are needed.
与健康足月儿相比,早产儿,尤其是患有慢性肺病(CLD)的早产儿,被认为更容易因呼吸道合胞病毒(RSV)感染而患上严重呼吸道疾病,因此是免疫球蛋白预防性给药的目标人群。迄今为止,这种做法对更严重的细支气管炎病例(即入住儿科重症监护病房[PICU]、机械通气、死亡)的影响尚未见报道。本研究的目的是评估在以色列引入RSV预防措施之前,因RSV细支气管炎导致的PICU入住情况、机械通气需求和死亡率。
对以色列11个PICU在RSV流行季节(2000年11月至2001年3月)进行前瞻性调查。
所有因细支气管炎入住PICU的患者,以及需要机械通气或死亡的亚组患者,均分析其已知风险因素,即早产、CLD和慢性氧依赖。
共有105例RSV细支气管炎患者符合纳入标准,其中33例接受了机械通气。大多数患者(总入院人数的84%,接受通气患者的88%)在妊娠32周后出生,分别有89%和88%的患者没有CLD。分别只有16%和9%的患者符合美国儿科学会的任何RSV预防标准,因此整个样本的84%和通气患者的91%不符合RSV预防条件。5例患者死亡,其中2例患有青紫型心脏病。
大多数患有严重RSV细支气管炎的婴儿为足月儿且没有CLD。因细支气管炎入住PICU的绝大多数患者不符合RSV预防条件。对预先定义的高危人群进行RSV预防,预计不会使PICU入住人数或需要机械通气的婴儿数量发生显著变化。需要新的RSV预防风险分层指南。